

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.82813294 |
| 2 | regulation of guanylate cyclase activity (GO:0031282) | 7.59988676 |
| 3 | NADH metabolic process (GO:0006734) | 6.60594520 |
| 4 | intestinal absorption (GO:0050892) | 6.49321067 |
| 5 | epoxygenase P450 pathway (GO:0019373) | 5.95628118 |
| 6 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.87432859 |
| 7 | lipoprotein transport (GO:0042953) | 5.69342487 |
| 8 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.51248163 |
| 9 | regulation of cellular extravasation (GO:0002691) | 5.42006016 |
| 10 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.20203417 |
| 11 | endocrine process (GO:0050886) | 5.20203417 |
| 12 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.20203417 |
| 13 | fructose metabolic process (GO:0006000) | 5.18488477 |
| 14 | hormone catabolic process (GO:0042447) | 5.03817812 |
| 15 | regulation of bile acid biosynthetic process (GO:0070857) | 4.97395428 |
| 16 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.76265509 |
| 17 | regulation of systemic arterial blood pressure (GO:0003073) | 4.70876909 |
| 18 | diacylglycerol metabolic process (GO:0046339) | 4.62211794 |
| 19 | regulation of cGMP biosynthetic process (GO:0030826) | 4.58190188 |
| 20 | drug metabolic process (GO:0017144) | 4.43978584 |
| 21 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.39913682 |
| 22 | renal system process involved in regulation of blood volume (GO:0001977) | 4.37567335 |
| 23 | positive regulation of pseudopodium assembly (GO:0031274) | 4.35633752 |
| 24 | antibacterial humoral response (GO:0019731) | 4.35216276 |
| 25 | adhesion of symbiont to host cell (GO:0044650) | 4.28349614 |
| 26 | virion attachment to host cell (GO:0019062) | 4.28349614 |
| 27 | antimicrobial humoral response (GO:0019730) | 4.27033257 |
| 28 | bile acid and bile salt transport (GO:0015721) | 4.25942666 |
| 29 | peptide catabolic process (GO:0043171) | 4.22360034 |
| 30 | regulation of vitamin metabolic process (GO:0030656) | 4.17092029 |
| 31 | cellular glucuronidation (GO:0052695) | 4.16737178 |
| 32 | urea cycle (GO:0000050) | 4.11838290 |
| 33 | glucuronate metabolic process (GO:0019585) | 4.11016706 |
| 34 | uronic acid metabolic process (GO:0006063) | 4.11016706 |
| 35 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.09538326 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.01630889 |
| 37 | peptide hormone processing (GO:0016486) | 3.98786123 |
| 38 | positive regulation of respiratory burst (GO:0060267) | 3.96855235 |
| 39 | urea metabolic process (GO:0019627) | 3.91850169 |
| 40 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.90209809 |
| 41 | regulation of pseudopodium assembly (GO:0031272) | 3.89950407 |
| 42 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.84786277 |
| 43 | regulation of cGMP metabolic process (GO:0030823) | 3.78238697 |
| 44 | glycosphingolipid catabolic process (GO:0046479) | 3.76351679 |
| 45 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.75122459 |
| 46 | glycolipid catabolic process (GO:0019377) | 3.72600584 |
| 47 | digestion (GO:0007586) | 3.72034718 |
| 48 | plasma lipoprotein particle assembly (GO:0034377) | 3.64744080 |
| 49 | cGMP-mediated signaling (GO:0019934) | 3.64384915 |
| 50 | nitrogen cycle metabolic process (GO:0071941) | 3.61442201 |
| 51 | adhesion of symbiont to host (GO:0044406) | 3.61298728 |
| 52 | vitamin transmembrane transport (GO:0035461) | 3.56698304 |
| 53 | alkaloid metabolic process (GO:0009820) | 3.56362707 |
| 54 | flavonoid metabolic process (GO:0009812) | 3.52303152 |
| 55 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.48928737 |
| 56 | cellular response to nitric oxide (GO:0071732) | 3.45966319 |
| 57 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.34811772 |
| 58 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.33847163 |
| 59 | protein-lipid complex assembly (GO:0065005) | 3.33823483 |
| 60 | digestive system process (GO:0022600) | 3.33813100 |
| 61 | vitamin A metabolic process (GO:0006776) | 3.31235270 |
| 62 | response to nitric oxide (GO:0071731) | 3.26872958 |
| 63 | vitamin transport (GO:0051180) | 3.26665669 |
| 64 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.26528548 |
| 65 | sulfate transmembrane transport (GO:1902358) | 3.25093998 |
| 66 | cellular response to reactive nitrogen species (GO:1902170) | 3.20077082 |
| 67 | drug catabolic process (GO:0042737) | 3.19830508 |
| 68 | epithelial structure maintenance (GO:0010669) | 3.19543250 |
| 69 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.18373571 |
| 70 | glomerular filtration (GO:0003094) | 3.14900031 |
| 71 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.14822665 |
| 72 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.13859958 |
| 73 | actin filament depolymerization (GO:0030042) | 3.13266836 |
| 74 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.13206327 |
| 75 | arginine metabolic process (GO:0006525) | 3.12076899 |
| 76 | lipoprotein metabolic process (GO:0042157) | 3.11740420 |
| 77 | transcytosis (GO:0045056) | 3.09873625 |
| 78 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.09001431 |
| 79 | positive regulation of lipid catabolic process (GO:0050996) | 3.08385234 |
| 80 | leukotriene metabolic process (GO:0006691) | 3.07558187 |
| 81 | drinking behavior (GO:0042756) | 3.05480016 |
| 82 | homocysteine metabolic process (GO:0050667) | 3.03803151 |
| 83 | glycerol metabolic process (GO:0006071) | 3.02847898 |
| 84 | glycosylceramide metabolic process (GO:0006677) | 3.02676215 |
| 85 | sexual reproduction (GO:0019953) | 3.01143799 |
| 86 | ceramide catabolic process (GO:0046514) | 3.01090615 |
| 87 | ethanol oxidation (GO:0006069) | 2.99692113 |
| 88 | drug transport (GO:0015893) | 2.98809408 |
| 89 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.96978838 |
| 90 | fat-soluble vitamin metabolic process (GO:0006775) | 2.96060586 |
| 91 | bile acid metabolic process (GO:0008206) | 2.95409377 |
| 92 | exogenous drug catabolic process (GO:0042738) | 2.95237480 |
| 93 | cGMP biosynthetic process (GO:0006182) | 2.93140326 |
| 94 | phospholipid efflux (GO:0033700) | 2.92941135 |
| 95 | sphingolipid catabolic process (GO:0030149) | 2.91613039 |
| 96 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.90963652 |
| 97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.90963652 |
| 98 | sphingomyelin metabolic process (GO:0006684) | 2.88568592 |
| 99 | regulation of cholesterol homeostasis (GO:2000188) | 2.87039839 |
| 100 | angiotensin maturation (GO:0002003) | 10.0081707 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.86941467 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.13522421 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.47798651 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.45923256 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.26346925 |
| 6 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.83021098 |
| 7 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.64274487 |
| 8 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.61864971 |
| 9 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.53206130 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.44197347 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.42488227 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.36504929 |
| 13 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.34101190 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.20509988 |
| 15 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.13957349 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.13697811 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.99035451 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.92403258 |
| 19 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.91587377 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.90983591 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.88252075 |
| 22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.85635347 |
| 23 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.82521225 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.82515114 |
| 25 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.81057139 |
| 26 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.79400852 |
| 27 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.78336283 |
| 28 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.72339133 |
| 29 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.70419446 |
| 30 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.66841481 |
| 31 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.59224888 |
| 32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.48533975 |
| 33 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.44045033 |
| 34 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.43360109 |
| 35 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.42368489 |
| 36 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.36620841 |
| 37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.35892831 |
| 38 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.34082575 |
| 39 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.33318551 |
| 40 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29718762 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26372353 |
| 42 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25660876 |
| 43 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.24024341 |
| 44 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23720155 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22366264 |
| 46 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21578481 |
| 47 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.20910930 |
| 48 | SA1_27219007_Chip-Seq_Bcells_Human | 1.20876652 |
| 49 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.19656243 |
| 50 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.19051164 |
| 51 | GATA2_19941826_ChIP-Seq_K562_Human | 1.17384121 |
| 52 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.15968573 |
| 53 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15820447 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.15308297 |
| 55 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.14380114 |
| 56 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13188745 |
| 57 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.11460432 |
| 58 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.10844231 |
| 59 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.10558982 |
| 60 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09775500 |
| 61 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09271857 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09261623 |
| 63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08696495 |
| 64 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.08184991 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07128772 |
| 66 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.05051233 |
| 67 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.04869377 |
| 68 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.04725746 |
| 69 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.01567825 |
| 70 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00612354 |
| 71 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00529155 |
| 72 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99108934 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98992658 |
| 74 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.98768120 |
| 75 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.97489289 |
| 76 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96607540 |
| 77 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95946020 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95879129 |
| 79 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95679527 |
| 80 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.95303459 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91697701 |
| 82 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.91458073 |
| 83 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90827855 |
| 84 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.90471233 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.90321950 |
| 86 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90300150 |
| 87 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.90059087 |
| 88 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.89765139 |
| 89 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.89713880 |
| 90 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.89362676 |
| 91 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.88210969 |
| 92 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.86699834 |
| 93 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85331124 |
| 94 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.84906705 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84305228 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.84121648 |
| 97 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.82695406 |
| 98 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82667427 |
| 99 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.82630721 |
| 100 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81441988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.87472058 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 4.36342917 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.34251712 |
| 4 | MP0001666_abnormal_nutrient_absorption | 4.32280006 |
| 5 | MP0003183_abnormal_peptide_metabolism | 4.01731993 |
| 6 | MP0009379_abnormal_foot_pigmentation | 3.70164633 |
| 7 | MP0005365_abnormal_bile_salt | 3.18421666 |
| 8 | MP0004019_abnormal_vitamin_homeostasis | 3.15649350 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 3.07111529 |
| 10 | MP0010155_abnormal_intestine_physiology | 3.06878256 |
| 11 | MP0004264_abnormal_extraembryonic_tissu | 3.03135534 |
| 12 | MP0004147_increased_porphyrin_level | 2.97926369 |
| 13 | MP0009840_abnormal_foam_cell | 2.95259581 |
| 14 | MP0003866_abnormal_defecation | 2.54114280 |
| 15 | MP0001664_abnormal_digestion | 2.10545613 |
| 16 | MP0005409_darkened_coat_color | 2.09838826 |
| 17 | MP0000490_abnormal_crypts_of | 2.06027056 |
| 18 | MP0003868_abnormal_feces_composition | 1.92466843 |
| 19 | MP0010352_gastrointestinal_tract_polyps | 1.84006689 |
| 20 | MP0010329_abnormal_lipoprotein_level | 1.79600313 |
| 21 | MP0009643_abnormal_urine_homeostasis | 1.69240099 |
| 22 | MP0005166_decreased_susceptibility_to | 1.66421408 |
| 23 | MP0000477_abnormal_intestine_morphology | 1.62179944 |
| 24 | MP0005332_abnormal_amino_acid | 1.61502816 |
| 25 | MP0000678_abnormal_parathyroid_gland | 1.59862503 |
| 26 | MP0001765_abnormal_ion_homeostasis | 1.59173663 |
| 27 | MP0003724_increased_susceptibility_to | 1.56348960 |
| 28 | MP0001873_stomach_inflammation | 1.54457674 |
| 29 | MP0001663_abnormal_digestive_system | 1.53322205 |
| 30 | MP0003252_abnormal_bile_duct | 1.47802128 |
| 31 | MP0004858_abnormal_nervous_system | 1.41011195 |
| 32 | MP0004043_abnormal_pH_regulation | 1.38727956 |
| 33 | MP0000538_abnormal_urinary_bladder | 1.37442402 |
| 34 | MP0001188_hyperpigmentation | 1.34786562 |
| 35 | MP0001764_abnormal_homeostasis | 1.33712135 |
| 36 | MP0002876_abnormal_thyroid_physiology | 1.32170875 |
| 37 | MP0005381_digestive/alimentary_phenotyp | 1.25576298 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 1.25400832 |
| 39 | MP0003806_abnormal_nucleotide_metabolis | 1.23243629 |
| 40 | MP0003303_peritoneal_inflammation | 1.23088457 |
| 41 | MP0005670_abnormal_white_adipose | 1.23029701 |
| 42 | MP0002136_abnormal_kidney_physiology | 1.22448031 |
| 43 | MP0004782_abnormal_surfactant_physiolog | 1.18296083 |
| 44 | MP0009785_altered_susceptibility_to | 1.17696237 |
| 45 | MP0003879_abnormal_hair_cell | 1.17436181 |
| 46 | MP0003436_decreased_susceptibility_to | 1.17371969 |
| 47 | MP0001835_abnormal_antigen_presentation | 1.15273298 |
| 48 | MP0002138_abnormal_hepatobiliary_system | 1.14422022 |
| 49 | MP0005451_abnormal_body_composition | 1.13850070 |
| 50 | MP0001845_abnormal_inflammatory_respons | 1.11004757 |
| 51 | MP0002118_abnormal_lipid_homeostasis | 1.09126645 |
| 52 | MP0000462_abnormal_digestive_system | 1.06374439 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.05782517 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.04399596 |
| 55 | MP0005025_abnormal_response_to | 1.03120678 |
| 56 | MP0003191_abnormal_cellular_cholesterol | 0.98034469 |
| 57 | MP0000609_abnormal_liver_physiology | 0.96585539 |
| 58 | MP0001501_abnormal_sleep_pattern | 0.94059393 |
| 59 | MP0005535_abnormal_body_temperature | 0.92004349 |
| 60 | MP0002796_impaired_skin_barrier | 0.91131469 |
| 61 | MP0001790_abnormal_immune_system | 0.90884726 |
| 62 | MP0005387_immune_system_phenotype | 0.90884726 |
| 63 | MP0002166_altered_tumor_susceptibility | 0.89545429 |
| 64 | MP0000230_abnormal_systemic_arterial | 0.89180490 |
| 65 | MP0005448_abnormal_energy_balance | 0.88811053 |
| 66 | MP0002971_abnormal_brown_adipose | 0.87953448 |
| 67 | MP0001756_abnormal_urination | 0.87777808 |
| 68 | MP0002822_catalepsy | 0.87455931 |
| 69 | MP0006082_CNS_inflammation | 0.86681484 |
| 70 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.85668811 |
| 71 | MP0008469_abnormal_protein_level | 0.83494219 |
| 72 | MP0004270_analgesia | 0.81248678 |
| 73 | MP0005319_abnormal_enzyme/_coenzyme | 0.81131023 |
| 74 | MP0002098_abnormal_vibrissa_morphology | 0.80174073 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 0.80168412 |
| 76 | MP0004947_skin_inflammation | 0.77438876 |
| 77 | MP0009115_abnormal_fat_cell | 0.76700928 |
| 78 | MP0002148_abnormal_hypersensitivity_rea | 0.75356916 |
| 79 | MP0002396_abnormal_hematopoietic_system | 0.74650891 |
| 80 | MP0001800_abnormal_humoral_immune | 0.74389039 |
| 81 | MP0005671_abnormal_response_to | 0.73526471 |
| 82 | MP0003718_maternal_effect | 0.73155488 |
| 83 | MP0000537_abnormal_urethra_morphology | 0.70395628 |
| 84 | MP0009764_decreased_sensitivity_to | 0.70208167 |
| 85 | MP0005310_abnormal_salivary_gland | 0.69663221 |
| 86 | MP0001533_abnormal_skeleton_physiology | 0.68944900 |
| 87 | MP0009642_abnormal_blood_homeostasis | 0.67549764 |
| 88 | MP0000249_abnormal_blood_vessel | 0.65557127 |
| 89 | MP0008260_abnormal_autophagy | 0.64957260 |
| 90 | MP0005666_abnormal_adipose_tissue | 0.62482878 |
| 91 | MP0005000_abnormal_immune_tolerance | 0.62225636 |
| 92 | MP0002419_abnormal_innate_immunity | 0.59996008 |
| 93 | MP0000604_amyloidosis | 0.59373232 |
| 94 | MP0000685_abnormal_immune_system | 0.58134687 |
| 95 | MP0002006_tumorigenesis | 0.57833552 |
| 96 | MP0002723_abnormal_immune_serum | 0.57452742 |
| 97 | MP0005501_abnormal_skin_physiology | 0.56751234 |
| 98 | MP0001485_abnormal_pinna_reflex | 0.56246854 |
| 99 | MP0002452_abnormal_antigen_presenting | 0.56236472 |
| 100 | MP0003329_amyloid_beta_deposits | 0.54489256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 9.44468843 |
| 2 | Malnutrition (HP:0004395) | 7.01241959 |
| 3 | Hydroxyprolinuria (HP:0003080) | 6.53392513 |
| 4 | Abnormality of proline metabolism (HP:0010907) | 6.53392513 |
| 5 | Chronic diarrhea (HP:0002028) | 5.17022048 |
| 6 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.74695593 |
| 7 | Ileus (HP:0002595) | 4.72525600 |
| 8 | Abnormality of vitamin B metabolism (HP:0004340) | 4.42295038 |
| 9 | Hyperactive renin-angiotensin system (HP:0000841) | 4.36166700 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 4.32505390 |
| 11 | Widely patent fontanelles and sutures (HP:0004492) | 4.22886575 |
| 12 | Metabolic alkalosis (HP:0200114) | 4.22269142 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 4.19760328 |
| 14 | Decreased circulating renin level (HP:0003351) | 4.13022566 |
| 15 | Confusion (HP:0001289) | 4.05834897 |
| 16 | Fat malabsorption (HP:0002630) | 4.04545854 |
| 17 | Acanthocytosis (HP:0001927) | 3.62292521 |
| 18 | Abnormality of vitamin metabolism (HP:0100508) | 3.55217207 |
| 19 | Alkalosis (HP:0001948) | 3.50593745 |
| 20 | Abnormality of renin-angiotensin system (HP:0000847) | 3.50157979 |
| 21 | Eczematoid dermatitis (HP:0000976) | 3.46345551 |
| 22 | Hyperglycinuria (HP:0003108) | 3.32235685 |
| 23 | Nausea (HP:0002018) | 3.31772048 |
| 24 | Thin bony cortex (HP:0002753) | 3.30966740 |
| 25 | Abdominal distention (HP:0003270) | 3.26884972 |
| 26 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.18667954 |
| 27 | Wide cranial sutures (HP:0010537) | 3.10970408 |
| 28 | Congenital sensorineural hearing impairment (HP:0008527) | 3.08627199 |
| 29 | Glycosuria (HP:0003076) | 3.08609836 |
| 30 | Abnormality of urine glucose concentration (HP:0011016) | 3.08609836 |
| 31 | Pigmentary retinal degeneration (HP:0001146) | 3.07115333 |
| 32 | Proximal tubulopathy (HP:0000114) | 3.01786084 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 2.85851432 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.85851432 |
| 35 | Nephrolithiasis (HP:0000787) | 2.82321313 |
| 36 | Hemorrhage of the eye (HP:0011885) | 2.77913323 |
| 37 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.77511868 |
| 38 | Villous atrophy (HP:0011473) | 2.77511868 |
| 39 | Hypophosphatemia (HP:0002148) | 2.76077555 |
| 40 | Hyperparathyroidism (HP:0000843) | 2.75922437 |
| 41 | Xanthomatosis (HP:0000991) | 2.71101214 |
| 42 | Facial shape deformation (HP:0011334) | 2.60139004 |
| 43 | Potter facies (HP:0002009) | 2.60139004 |
| 44 | Increased purine levels (HP:0004368) | 2.58568313 |
| 45 | Hyperuricemia (HP:0002149) | 2.58568313 |
| 46 | Flat acetabular roof (HP:0003180) | 2.56875338 |
| 47 | Posterior subcapsular cataract (HP:0007787) | 2.52906343 |
| 48 | Steatorrhea (HP:0002570) | 2.50304212 |
| 49 | Hyperammonemia (HP:0001987) | 2.49266259 |
| 50 | Megaloblastic anemia (HP:0001889) | 2.47036830 |
| 51 | Hypotension (HP:0002615) | 2.39544282 |
| 52 | Right ventricular cardiomyopathy (HP:0011663) | 2.38787007 |
| 53 | Gingivitis (HP:0000230) | 2.36384760 |
| 54 | Focal segmental glomerulosclerosis (HP:0000097) | 2.36318333 |
| 55 | Enlarged epiphyses (HP:0010580) | 2.27267482 |
| 56 | Glomerulonephritis (HP:0000099) | 2.25139764 |
| 57 | Abnormality of purine metabolism (HP:0004352) | 2.24386286 |
| 58 | Hyperphosphatemia (HP:0002905) | 2.23127593 |
| 59 | Abnormal urine phosphate concentration (HP:0012599) | 2.18104319 |
| 60 | Delayed epiphyseal ossification (HP:0002663) | 2.14793985 |
| 61 | Abnormality of the costochondral junction (HP:0000919) | 2.13994432 |
| 62 | Abnormality of nucleobase metabolism (HP:0010932) | 2.12516172 |
| 63 | Hypolipoproteinemia (HP:0010981) | 2.12180081 |
| 64 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.10003486 |
| 65 | Gastrointestinal dysmotility (HP:0002579) | 2.07483150 |
| 66 | Abnormality of complement system (HP:0005339) | 2.07349692 |
| 67 | Hyperphosphaturia (HP:0003109) | 2.06253265 |
| 68 | Renal tubular acidosis (HP:0001947) | 2.05752407 |
| 69 | Pancreatitis (HP:0001733) | 2.05602787 |
| 70 | Hyperaldosteronism (HP:0000859) | 2.05442705 |
| 71 | Abnormality of chloride homeostasis (HP:0011422) | 2.03469405 |
| 72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.03109136 |
| 73 | Dicarboxylic aciduria (HP:0003215) | 2.03109136 |
| 74 | Cerebral palsy (HP:0100021) | 2.02635003 |
| 75 | Petechiae (HP:0000967) | 1.98982547 |
| 76 | Metabolic acidosis (HP:0001942) | 1.98401092 |
| 77 | Nephritis (HP:0000123) | 1.97923168 |
| 78 | Hypokalemia (HP:0002900) | 1.97187933 |
| 79 | Protuberant abdomen (HP:0001538) | 1.96972001 |
| 80 | Growth hormone excess (HP:0000845) | 1.96320140 |
| 81 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.95823084 |
| 82 | Abnormality of magnesium homeostasis (HP:0004921) | 1.91561274 |
| 83 | Complement deficiency (HP:0004431) | 1.89967263 |
| 84 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.86617741 |
| 85 | Subcapsular cataract (HP:0000523) | 1.86293000 |
| 86 | Pili torti (HP:0003777) | 1.82691217 |
| 87 | Abnormal glucose tolerance (HP:0001952) | 1.80487350 |
| 88 | Glomerulosclerosis (HP:0000096) | 1.77098053 |
| 89 | Multiple lipomas (HP:0001012) | 1.77021725 |
| 90 | Dehydration (HP:0001944) | 1.76372244 |
| 91 | Epidermoid cyst (HP:0200040) | 1.76058984 |
| 92 | Intrahepatic cholestasis (HP:0001406) | 1.74672033 |
| 93 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.73181459 |
| 94 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.72784848 |
| 95 | Hypocalcemia (HP:0002901) | 1.72469379 |
| 96 | Conjugated hyperbilirubinemia (HP:0002908) | 1.72050164 |
| 97 | Bone pain (HP:0002653) | 1.71189714 |
| 98 | Irritability (HP:0000737) | 1.71050438 |
| 99 | Abnormal tarsal ossification (HP:0008369) | 1.70795126 |
| 100 | Abnormality of potassium homeostasis (HP:0011042) | 1.69023536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 7.10024505 |
| 2 | ERN1 | 4.91400505 |
| 3 | MST1R | 4.64336415 |
| 4 | RIPK1 | 3.63060816 |
| 5 | PRKG2 | 3.24125950 |
| 6 | EPHA2 | 2.89178373 |
| 7 | MAP3K10 | 2.68303412 |
| 8 | RIPK4 | 2.23846410 |
| 9 | PIK3CA | 2.08801544 |
| 10 | TESK2 | 2.01975432 |
| 11 | TYK2 | 1.91923014 |
| 12 | PTK6 | 1.87959646 |
| 13 | MAP4K1 | 1.86844985 |
| 14 | EPHB1 | 1.82848592 |
| 15 | FGFR4 | 1.77788102 |
| 16 | GRK6 | 1.66679334 |
| 17 | EPHB2 | 1.62012122 |
| 18 | MET | 1.57856328 |
| 19 | EPHA3 | 1.48150413 |
| 20 | STK39 | 1.43045637 |
| 21 | MAP3K12 | 1.42372933 |
| 22 | MAP3K2 | 1.42290009 |
| 23 | PRPF4B | 1.39038622 |
| 24 | OXSR1 | 1.38157155 |
| 25 | MAP3K1 | 1.33521361 |
| 26 | PDK2 | 1.30859022 |
| 27 | LMTK2 | 1.27037324 |
| 28 | MATK | 1.23913386 |
| 29 | DDR2 | 1.14307244 |
| 30 | STK24 | 1.14109855 |
| 31 | MAP2K2 | 1.12202966 |
| 32 | TAOK1 | 1.05727540 |
| 33 | MAP3K11 | 1.04456101 |
| 34 | PDPK1 | 0.96587225 |
| 35 | MYLK | 0.94069282 |
| 36 | TNIK | 0.93989492 |
| 37 | FGFR3 | 0.93923560 |
| 38 | TESK1 | 0.92620009 |
| 39 | NLK | 0.91253231 |
| 40 | CDC42BPA | 0.90263910 |
| 41 | CSK | 0.87527576 |
| 42 | TBK1 | 0.80926566 |
| 43 | MST4 | 0.80229804 |
| 44 | IRAK4 | 0.80224094 |
| 45 | MAP2K6 | 0.79988199 |
| 46 | ERBB2 | 0.78146992 |
| 47 | EPHA4 | 0.75991739 |
| 48 | ZAP70 | 0.74334103 |
| 49 | PDK1 | 0.73557683 |
| 50 | IKBKE | 0.70414059 |
| 51 | KSR2 | 0.67643052 |
| 52 | CDK19 | 0.66665826 |
| 53 | DYRK1B | 0.65939827 |
| 54 | IRAK1 | 0.65401219 |
| 55 | JAK2 | 0.64736544 |
| 56 | MAP3K3 | 0.62485279 |
| 57 | PRKAA2 | 0.61905735 |
| 58 | JAK1 | 0.60723490 |
| 59 | YES1 | 0.60170691 |
| 60 | PRKACG | 0.59807249 |
| 61 | BMPR2 | 0.59573308 |
| 62 | MAP3K14 | 0.57963665 |
| 63 | AKT3 | 0.57227480 |
| 64 | MAPK11 | 0.55966778 |
| 65 | PRKCZ | 0.55225045 |
| 66 | JAK3 | 0.54438609 |
| 67 | BTK | 0.54168956 |
| 68 | PIM1 | 0.53328975 |
| 69 | TRIB3 | 0.51025046 |
| 70 | FER | 0.49886921 |
| 71 | FYN | 0.48524013 |
| 72 | RET | 0.48024607 |
| 73 | SYK | 0.48005668 |
| 74 | CSF1R | 0.47708710 |
| 75 | PRKCA | 0.47684051 |
| 76 | LYN | 0.46886164 |
| 77 | PAK4 | 0.46229671 |
| 78 | ITK | 0.45433598 |
| 79 | BLK | 0.44911474 |
| 80 | SRC | 0.44000155 |
| 81 | CAMK2D | 0.41561892 |
| 82 | SMG1 | 0.38229442 |
| 83 | ABL2 | 0.37476363 |
| 84 | FGR | 0.36577401 |
| 85 | KIT | 0.35746679 |
| 86 | PRKCD | 0.34246640 |
| 87 | PTK2 | 0.32580400 |
| 88 | LCK | 0.32246656 |
| 89 | RPS6KA2 | 0.31200582 |
| 90 | DAPK2 | 0.30696010 |
| 91 | BMX | 0.29312146 |
| 92 | LRRK2 | 0.28249640 |
| 93 | MAPKAPK2 | 0.27767611 |
| 94 | TEC | 0.27757261 |
| 95 | PRKCQ | 0.26510765 |
| 96 | DMPK | 0.25298176 |
| 97 | MAP3K8 | 0.23782126 |
| 98 | HCK | 0.22116717 |
| 99 | MAPK7 | 0.21690324 |
| 100 | CDK6 | 0.21572869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.96960484 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.18289411 |
| 3 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.92331133 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.80292053 |
| 5 | Mineral absorption_Homo sapiens_hsa04978 | 2.75282367 |
| 6 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.30167484 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.26731276 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.25471262 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.23106458 |
| 10 | Histidine metabolism_Homo sapiens_hsa00340 | 2.19125878 |
| 11 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.14095116 |
| 12 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.11308487 |
| 13 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.09834803 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.04348967 |
| 15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.01528619 |
| 16 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.96695356 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.93002888 |
| 18 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.83415623 |
| 19 | Galactose metabolism_Homo sapiens_hsa00052 | 1.77778500 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.74295295 |
| 21 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73084450 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.72358640 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70687241 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.68645170 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.66597347 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.65330190 |
| 27 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.60730927 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.52918955 |
| 29 | Asthma_Homo sapiens_hsa05310 | 1.46256618 |
| 30 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.32775193 |
| 31 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.32182375 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.29927482 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.29492806 |
| 34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.24662777 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.20239509 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.18003401 |
| 37 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.17640433 |
| 38 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.12324473 |
| 39 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.12279444 |
| 40 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.09926090 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.07721994 |
| 42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.07348960 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.00011651 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.98593004 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.90715281 |
| 46 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.90059110 |
| 47 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85775292 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84118833 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.75384264 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74762790 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69654163 |
| 52 | Leishmaniasis_Homo sapiens_hsa05140 | 0.69214496 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68798126 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68699844 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67321048 |
| 56 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.63911991 |
| 57 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.63756791 |
| 58 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.60680245 |
| 59 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58183113 |
| 60 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54981651 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46648762 |
| 62 | Renin secretion_Homo sapiens_hsa04924 | 0.43327562 |
| 63 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.42143477 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.41371544 |
| 65 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.39541084 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.39469520 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37973636 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.37342087 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.37178407 |
| 70 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.37004956 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36189819 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35395660 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.33815089 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33665571 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.32025419 |
| 76 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.30731153 |
| 77 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.28821623 |
| 78 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.28636654 |
| 79 | Tuberculosis_Homo sapiens_hsa05152 | 0.25737285 |
| 80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.24887000 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.24506685 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.22216969 |
| 83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.21091477 |
| 84 | Influenza A_Homo sapiens_hsa05164 | 0.20905389 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.20710907 |
| 86 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.20385126 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.19563824 |
| 88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.17566762 |
| 89 | Tight junction_Homo sapiens_hsa04530 | 0.14532831 |
| 90 | Cocaine addiction_Homo sapiens_hsa05030 | 0.13996573 |
| 91 | Carbon metabolism_Homo sapiens_hsa01200 | 0.13990346 |
| 92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.12560886 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.12524205 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.11301701 |
| 95 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08996575 |
| 96 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.08975472 |
| 97 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.08419739 |
| 98 | Insulin secretion_Homo sapiens_hsa04911 | 0.07747901 |
| 99 | Salmonella infection_Homo sapiens_hsa05132 | 0.05217571 |
| 100 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.04218778 |

